Diagnos Inc. (ADK.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 03-2015 | 03-2014 | 03-2013 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 82 | 44 | 62 | 90 | 81 |
| Accounts receivable | N/A | -136 | -1 | -435 | 18 |
| Accounts payable and accrued liabilities | N/A | -241 | 81 | 168 | 18 |
| Other Working Capital | 84 | -237 | 145 | -308 | -54 |
| Other Operating Activity | -2,400 | -2,296 | -1,501 | -1,523 | -1,970 |
| Operating Cash Flow | $-2,233 | $-2,866 | $-1,214 | $-2,008 | $-1,907 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -177 | -21 | -7 | -54 | -54 |
| Net Acquisitions | 0 | -1 | N/A | N/A | N/A |
| Purchase Of Investment | -1,000 | -1,507 | -41 | -246 | -2,625 |
| Sale Of Investment | 1,059 | 1,400 | 73 | 2,028 | 1,382 |
| Purchase Sale Intangibles | -27 | -15 | -14 | -30 | -12 |
| Other Investing Activity | 16 | -3 | 0 | 2 | 2 |
| Investing Cash Flow | $-130 | $-145 | $11 | $1,699 | $-1,309 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,168 | 250 | 669 | N/A | N/A |
| Common Stock Issued | 2 | 2,110 | N/A | N/A | N/A |
| Other Financing Activity | 318 | 129 | 58 | 1,385 | 3,144 |
| Financing Cash Flow | $2,488 | $2,489 | $727 | $1,385 | $3,144 |
| Beginning Cash Position | 352 | 875 | 1,351 | 276 | 347 |
| End Cash Position | 477 | 352 | 875 | 1,351 | 276 |
| Net Cash Flow | $125 | $-523 | $-476 | $1,075 | $-72 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,233 | -2,866 | -1,214 | -2,008 | -1,907 |
| Capital Expenditure | -204 | -35 | -21 | -85 | -68 |
| Free Cash Flow | -2,437 | -2,902 | -1,235 | -2,093 | -1,975 |